There is a clear need for more research in this area
Working With Healthcare Providers For Canadian patients pursuing FDA-approved medications once Retatrutide receives approval, the process typically involves initial consultation to establish obesity diagnosis and discuss treatment options, baseline laboratory work including metabolic panel, lipid profile, and A1C if diabetic, discussion of contraindications and potential drug interactions, prescription and prior authorization if required by insurance, and scheduled follow-up appointments for monitoring
Patients and physicians will need to choose based on individual circumstances: the convenience and accessibility of Foundayo vs the superior efficacy of retatrutide
Doctors regularly use blood and urine tests to monitor the effectiveness of Ozempic and check for potential complications, such as pancreatitis or gallstones
Some people may have a family history of psychosis or mood disorders, says Cooper